SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020276
Filing Date
2020-11-02
Accepted
2020-11-02 08:00:43
Documents
80
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1354549
2 ex10-1.htm EX-10.1 144646
3 ex10-2.htm EX-10.2 395728
4 ex31-1.htm EX-31.1 18025
5 ex31-2.htm EX-31.2 18011
6 ex32-1.htm EX-32.1 6345
7 ex32-2.htm EX-32.2 6478
  Complete submission text file 0001493152-20-020276.txt   6824042

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE vbiv-20200930.xsd EX-101.SCH 61737
9 XBRL CALCULATION FILE vbiv-20200930_cal.xml EX-101.CAL 65840
10 XBRL DEFINITION FILE vbiv-20200930_def.xml EX-101.DEF 217331
11 XBRL LABEL FILE vbiv-20200930_lab.xml EX-101.LAB 448386
12 XBRL PRESENTATION FILE vbiv-20200930_pre.xml EX-101.PRE 333314
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 872193
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 201279012
SIC: 2834 Pharmaceutical Preparations